Compugen Stock Analysis

CGEN Stock  USD 1.55  0.03  1.97%   
Compugen holds a debt-to-equity ratio of 0.024. At this time, Compugen's Short Term Debt is very stable compared to the past year. As of the 7th of January 2026, Net Debt To EBITDA is likely to grow to 1.67, while Net Debt is likely to drop (14.5 M). With a high degree of financial leverage come high-interest payments, which usually reduce Compugen's Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

Compugen's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Compugen's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Compugen Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Compugen's stakeholders.
For most companies, including Compugen, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Compugen, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Compugen's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
3.3081
Book Value
0.469
Operating Margin
(4.17)
Return On Assets
(0.18)
Return On Equity
(0.53)
At this time, Compugen's Total Current Liabilities is very stable compared to the past year. As of the 7th of January 2026, Non Current Liabilities Total is likely to grow to about 48.2 M, while Liabilities And Stockholders Equity is likely to drop about 72.9 M.
Compugen is undervalued with Real Value of 2.66 and Target Price of 6.25. The main objective of Compugen stock analysis is to determine its intrinsic value, which is an estimate of what Compugen is worth, separate from its market price. There are two main types of Compugen's stock analysis: fundamental analysis and technical analysis.
The Compugen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Compugen is usually not traded on Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday. Compugen Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

Compugen Stock Analysis Notes

About 14.0% of the company shares are held by institutions such as insurance companies. The book value of Compugen was currently reported as 0.47. The company recorded a loss per share of 0.3. Compugen had not issued any dividends in recent years. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. Compugen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 73 people. For more info on Compugen please contact Anat CohenDayag at 972 3 765 8585 or go to https://cgen.com.

Compugen Investment Alerts

Compugen generated a negative expected return over the last 90 days
Compugen may become a speculative penny stock
Compugen has high historical volatility and very poor performance
The company reported the previous year's revenue of 27.86 M. Net Loss for the year was (14.23 M) with profit before overhead, payroll, taxes, and interest of 513 K.
Latest headline from seekingalpha.com: Corbus declines following early-stage results on oral obesity asset CRB-913

Compugen Upcoming and Recent Events

Earnings reports are used by Compugen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
26th of February 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Compugen Largest EPS Surprises

Earnings surprises can significantly impact Compugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2011-11-08
2011-09-30-0.09-0.1-0.0111 
2011-05-11
2011-03-31-0.07-0.060.0114 
2010-02-09
2009-12-31-0.08-0.070.0112 
View All Earnings Estimates

Compugen Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 145.91 M.

Compugen Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.14)(0.15)
Return On Capital Employed(0.14)(0.15)
Return On Assets(0.14)(0.15)
Return On Equity(0.30)(0.31)

Management Efficiency

Compugen has return on total asset (ROA) of (0.1818) % which means that it has lost $0.1818 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5295) %, meaning that it created substantial loss on money invested by shareholders. Compugen's management efficiency ratios could be used to measure how well Compugen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 7th of January 2026, Return On Tangible Assets is likely to drop to -0.15. In addition to that, Return On Capital Employed is likely to drop to -0.15. At this time, Compugen's Asset Turnover is very stable compared to the past year.
Last ReportedProjected for Next Year
Book Value Per Share 0.71  0.67 
Tangible Book Value Per Share 0.71  0.67 
Enterprise Value Over EBITDA(9.71)(10.20)
Price Book Value Ratio 2.24  3.62 
Enterprise Value Multiple(9.71)(10.20)
Price Fair Value 2.24  3.62 
Enterprise Value109.5 M144.9 M
Compugen benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Operating Margin
(4.17)
Beta
2.855
Return On Assets
(0.18)
Return On Equity
(0.53)

Technical Drivers

As of the 7th of January, Compugen shows the Risk Adjusted Performance of (0.01), mean deviation of 3.03, and Standard Deviation of 4.42. Compugen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Compugen Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Parabolic SAR indicator is used to determine the direction of Compugen's momentum and the point in time when Compugen has higher than normal probability directional change.

Compugen Outstanding Bonds

Compugen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Compugen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Compugen bonds can be classified according to their maturity, which is the date when Compugen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Compugen Predictive Daily Indicators

Compugen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Compugen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Compugen Forecast Models

Compugen's time-series forecasting models are one of many Compugen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Compugen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Compugen Bond Ratings

Compugen financial ratings play a critical role in determining how much Compugen have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Compugen's borrowing costs.
Piotroski F Score
6
HealthyView
Beneish M Score
(7.18)
Unlikely ManipulatorView

Compugen Debt to Cash Allocation

As Compugen follows its natural business cycle, the capital allocation decisions will not magically go away. Compugen's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Compugen currently holds 2.91 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Compugen has a current ratio of 6.04, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Compugen's use of debt, we should always consider it together with its cash and equity.

Compugen Total Assets Over Time

Compugen Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Compugen uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Compugen Debt Ratio

    
  3.07   
It appears that most of the Compugen's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Compugen's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Compugen, which in turn will lower the firm's financial flexibility.

Compugen Corporate Bonds Issued

Compugen Net Debt

Net Debt

(14.47 Million)

Compugen reported last year Net Debt of (13.79 Million)

About Compugen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Compugen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Compugen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Compugen. By using and applying Compugen Stock analysis, traders can create a robust methodology for identifying Compugen entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.31)(0.33)
Operating Profit Margin(0.48)(0.51)
Net Loss(0.46)(0.48)
Gross Profit Margin 0.82  0.87 

Current Compugen Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Compugen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Compugen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
6.25Strong Buy4Odds
Compugen current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Compugen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Compugen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Compugen, talking to its executives and customers, or listening to Compugen conference calls.
Compugen Analyst Advice Details

Compugen Stock Analysis Indicators

Compugen stock analysis indicators help investors evaluate how Compugen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Compugen shares will generate the highest return on investment. By understating and applying Compugen stock analysis, traders can identify Compugen position entry and exit signals to maximize returns.
Begin Period Cash Flow14.3 M
Common Stock Shares Outstanding89.5 M
Total Stockholder Equity54.9 M
Total Cashflows From Investing Activities-46.3 M
Tax Provision4.5 M
Property Plant And Equipment Net3.7 M
Cash And Short Term Investments103.3 M
Cash18.2 M
Accounts Payable1.8 M
Net Debt-15.3 M
50 Day M A1.5928
Total Current Liabilities20.2 M
Other Operating Expenses42.8 M
Non Current Assets TotalM
Non Currrent Assets Other5.3 M
Stock Based CompensationM
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.30)
Revenue Per Share
0.075
Quarterly Revenue Growth
(0.89)
Return On Assets
(0.18)
Return On Equity
(0.53)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.